Skip to Content

CEL-SCI Corp CVM Stock Quote

| Rating as of

XASE: CVM

Pre-Market: 1.20 0.00 | 0.00 %

| Currency in USD

  • Last Close 1.20
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Blend
  • Day Range 1.15  –  1.25
  • Year Range 1.08  –  3.68
  • Market Cap 56.7121 Mil
  • Volume / Avg 17.0 /  336,810.0
  • Price / Sales
  • Price / Book 3.63
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CVM

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CVM

Company Profile CVM

Business Description

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Contact
8229 Boone Boulevard, Suite 802
Vienna, VA, 22182
Industry Biotechnology
Employees 44

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

CEL-SCI Corp

XASE: CVM

AIM ImmunoTech Inc

XASE: AIM

Cardiff Oncology Inc

XNAS: CRDF

Atossa Therapeutics Inc

XNAS: ATOS
Price
1.200.511.610.77
Currency
USDUSDUSDUSD
Change
−$0.08 (6.25%) −$0.06 (11.06%) $0.00 (0.00%) −$0.06 (7.10%)
Market Cap
56.71 Mil24.79 Mil71.93 Mil96.99 Mil
Industry
Biotechnology Biotechnology Biotechnology Biotechnology
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for CEL-SCI Corp Stock

No. CVM does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CVM’s market cap is 56.71 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CVM’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CVM’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CVM’s historical performance against its industry peers and the overall market.